Cytarabine-induced pericarditis confirmed using cardiac MRI: A case report.
Tony DongTarek ChamiBesher ChamiSadeer Al-KindiBrian D HoitPublished in: Echocardiography (Mount Kisco, N.Y.) (2021)
Pericarditis is a rare but debilitating complication of cytarabine therapy. While echocardiography can aid with the diagnosis, cardiac MRI has superior accuracy in establishing the diagnosis. In this case, we describe a 65-year-old patient receiving cytarabine as part of induction chemotherapy for acute myeloid leukemia who developed acute pericarditis. Her cardiac MRI revealed pericardial edema on T2-weighted STIR imaging and pericardial late gadolinium enhancement which confirmed the diagnosis.
Keyphrases
- acute myeloid leukemia
- contrast enhanced
- left ventricular
- magnetic resonance imaging
- high dose
- computed tomography
- allogeneic hematopoietic stem cell transplantation
- diffusion weighted imaging
- magnetic resonance
- liver failure
- high resolution
- drug induced
- case report
- squamous cell carcinoma
- stem cells
- diabetic rats
- bone marrow
- locally advanced
- atrial fibrillation
- intensive care unit
- single cell
- pulmonary hypertension
- photodynamic therapy
- mass spectrometry
- respiratory failure
- endothelial cells
- smoking cessation